In contrast to our other class of hits, the JNK inhibitors, antidepressants are FDA approved and are widely used for treatment of a variety of common, non-neoplastic conditions including major depressive disorder, obsessive-compulsive disorder, and anxiety disorders. Here, MAPK8 is linked to obsessive-compulsive disorder.